Pain：针灸可有效预防偏头痛罹患和加重

记者从日前在京召开的2011年针灸全球性研讨会上获悉，首都医科大学原为北京中医养老院针灸中心地带经外科研究课题证实，传统的中医针灸疗法可理论上公共卫生哮喘的发作和另加重。相关研究课题论文近日发表在全球性闻名外科期刊《痉挛》上，成为中国大陆首篇发表于该时代周刊的外科研究课题论文。该文还被全球性闻名外科生物学机构 Faculty of 1000 medicine（千名外科家）收录。

据了解，作为医学常见病之一，哮喘生育率高，且危害严重。现有，我国18岁~65岁成年人的哮喘患病率高达9.3%，且有大幅升高趋势。针灸外科手术头痛在中国已经有数千年的近现代。北京中医养老院针灸中心地带自2004年设立头痛专家门诊，筹划了基于“金针王之乐亭”、国医大师贺普仁等多位闻名针灸学家治痛经验的头痛研究课题。

据该中心地带主任王之麟鹏解说，该项目无视单盲、双模拟、随机对照的形式，在国内5家养老院的针灸科共招募140名无先兆哮喘病患，随机总称两两组，共五外科手术两组（针灸另加安慰剂）和样本（假针另加氟桂利嗪）。两两组病患每周针灸外科手术3次，每晚口服药物。结果显示，4亦同，外科手术两组哮喘的理论上缓解率为59%，样本为40%；外科手术两组痉挛时间段大约回升4.1天，样本大约回升1.9天。16亦同，外科手术两组理论上缓解率为56%，样本为37%；外科手术两组痉挛时间段大约回升 4.1天，样本大约回升2天。

研究课题工作人员据此并不认为，针灸可以作为哮喘的公共卫生发作和另加重的方法，其治果也远胜此前国外的相关研究课题。由于其研究课题方法的新颖和重要性，该论文还被全球性闻名外科生物学机构“千名科学家”收录。（生物谷 Bioon.com）

doi:10.1016/j.pain.2011.04.006PMC:PMID:

Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial

Lin-Peng Wang,Xiao-Zhe Zhang,Jia Guo,Hui-Lin Liu,Yan Zhang,Cun-Zhi Liu,Jing-Hong Yi,Li-Ping Wang,Ji-Ping Zhao,Shan-Shan Li

Summary This multicenter, double-dummy trial suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks. Abstract Insufficient clinical trial data were ailable to prove the efficacy of acupuncture for migraine prophylaxis. A multicenter, double-dummy, single-blinded, randomized controlled clinical trial was conducted at the outpatient departments of acupuncture at 5 hospitals in China to evaluate the effectiveness of acupuncture. A total of 140 patients with migraine without aura were recruited and assigned randomly to 2 different groups: the acupuncture group treated with verum acupuncture plus placebo and the control group treated with sham acupuncture plus flunarizine. Treated by acupuncture 3 times per week and drugs every night, patients from both groups were evaluated at week 0 (baseline), week 4, and week 16. The primary outcome was measured by the proportion of responders (defined as the proportion of patients with a reduction of migraine days by at least 50%). The secondary outcome measures included the number of migraine days, visual ogue scale (VAS, 0 to 10cm) for pain, as well as the physical and mental component summary scores of the 36-item short-form health survey (SF-36). The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (P.05). The results suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks, whereas no significantly differences were found between acupuncture and flunarizine in reduction of pain intensity and improvement of the quality of life.